YOLFTbeta
Jack Nathan Medical Corp

Jack Nathan Medical Corp

JNH · V · Healthcare / Medical Care Facilities

0.01CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.01
Open0.01
Day Range0.01 – 0.01
52-Week Range0.01 – 0.01
Volume0
Market Cap870.99K
P/E (TTM)0.00
Forward P/E0.00
EPS-0.08
Dividend Yield0.00%
Beta-0.19
50-Day Avg0.01
200-Day Avg0.01

About

Jack Nathan Medical Corp., together with its subsidiaries, designs, builds, and operates medical clinics in Canada and Mexico. It operates Jack Nathan MedSpa, a aesthetic wellness platform that provides aesthetic and wellness services, including injectables, skin rejuvenation, laser treatments and therapies, skin care therapies, and wellness treatments. In addition, the company's platform also supports primary care, virtual care, and a range of allied health services, such as physiotherapy, chiropractic, skincare, and wellness. The company was founded in 2006 and is headquartered in Woodbridge, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Michael Di Cesare
  • Employees0
  • Headquarters6-6150 Highway 7, Woodbridge, ON, Canada, Canada
  • Websitehttps://www.jacknathanhealth.com

Leadership

  • Dr. Glenn CopelandPresident, Chief Medical Officer & Director
  • Ms. Marcy HerrimanChief Operating Officer
  • Mr. Michael Di CesareInterim CEO & Chairman of the Board
  • Mr. David ParralesInterim Chief Financial Officer
  • Mr. Serge CinelliChief Technology Officer

Financials

Income Statement

Currency: CAD2019-01-312020-01-312021-01-312022-01-312023-01-312023-12-31
Total Revenue003.85M9.64M15.49M17.42M
Growth (%)---+150.21%+60.68%+12.48%
Cost of Revenue--74.43K2.71M3.67M4.56M
Gross Profit--3.78M6.92M11.82M12.86M
Gross Margin--98.07%71.84%76.31%73.80%
Operating Expense--4.65M13.87M17.12M17.57M
Operating Income-18.09K-134.62K-876.24K-6.94M-5.31M-4.72M
Operating Margin---22.75%-72.04%-34.26%-27.07%
EBITDA---10.11M-7.54M-5.51M-
EBITDA Margin---262.53%-78.18%-35.57%-
Net Income-18.09K-134.62K-9.91M-7.81M-7.08M-
Net Income Margin---257.34%-81.00%-45.69%-
R&D--102.00K546.06K236.93K149.91K
R&D as % of Total Revenue--2.65%5.67%1.53%0.86%
Interest Expense0036.23K181.85K409.51K-
Interest Expense % of Total Revenue--0.94%1.89%2.64%-

Balance Sheet

Currency: CAD2019-01-312020-01-312021-01-312022-01-312023-01-31
Total Assets84.20K406.78K10.65M8.14M6.45M
Total Liabilities8.00K17.18K2.13M4.06M8.32M
Total Equity76.20K389.59K8.53M4.08M-1.87M
Cash84.20K406.78K7.69M1.06M1.46M
Net Debt-750.02K--2.33M

Cash Flow

Currency: CAD2019-01-312020-01-312021-01-312022-01-312023-01-312023-12-31
Operating Cash Flow485.65K-375.55K-809.16K-4.34M-2.00M-
Investing Cash Flow-274.08K-255.49K-252.89K-2.14M-2.76M-
Financing Cash Flow12.07K166.66K8.68M-164.43K5.35M12.66M
Capital Expenditure274.08K255.49K499.74K950.90K2.59M3.93M
Free Cash Flow-33.69K-66.53K-1.31M-5.29M-4.59M-8.92M
FCF to OCF-6.94%17.72%161.76%121.91%228.98%-

Earnings

Report DateSep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Oct 31, 2020Jan 31, 2021Apr 30, 2021Jul 31, 2021Oct 31, 2021Jan 31, 2022Apr 30, 2022Jul 31, 2022Oct 31, 2022Jan 31, 2023Apr 30, 2023Oct 5, 2026
EPS Estimate----------------
EPS Actual-0.00-0.01-0.05-0.04-0.16-0.03-0.02-0.02-0.03-0.03-0.02-0.02-0.01-0.04-0.01-
Surprise----------------
Timing---------------After-hours

Key Statistics & Ratios

Market Cap870.99K
Enterprise Value7.19M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.25
Price / Book7.84
EPS-0.08
Book Value-0.023
Revenue (TTM)-6.71M
Gross Profit (TTM)-5.42M
EBITDA692.35K
Profit Margin0.00%
Operating Margin-472.66%
Return on Equity-1961.56%
Return on Assets9.45%
Shares Outstanding87.10M
Shares Float55.51M
Beta-0.19
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 6, 20201:3